Hydroxytyrosol Cinnamic Acid Ester Synthesis for Resistant Bacteria

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antibiotics are ineffective against rapidly emerging antibiotic-resistant bacteria such as MRSA, PRSP, multi-resistant tuberculosis, and VRE, necessitating the development of new antibacterial agents.

Innovation Solution

A hydroxytyrosol cinnamic acid ester is synthesized by reacting hydroxytyrosol with cinnamic acid in specific molar ratios, using organic solvents and catalysts, and purified through chromatography or recrystallization, to produce a compound with enhanced antibacterial and antioxidant properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing antibiotics are used, then treatment of common bacterial infections is effective, but they are ineffective against antibiotic-resistant bacteria such as MRSA, PRSP, and VRE

Engineering Contradiction:
Improveantibacterial effectivenessVSAvoidspectrum of antibacterial activity
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention combines hydroxytyrosol and cinnamic acid to create a composite ester compound that exhibits both antioxidant and antibacterial properties. This composite structure enables the compound to effectively target antibiotic-resistant bacteria while maintaining the beneficial antioxidant effects of the original phenolic compound.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention modifies the chemical structure by forming an ester bond between hydroxytyrosol and cinnamic acid, changing the molecular parameters to create a new compound with enhanced antibacterial activity against resistant strains while retaining antioxidant properties.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If hydroxytyrosol is modified by cinnamic acid structure, then antibacterial activity against resistant bacteria is enhanced, but the complexity of synthesis and purification increases

Engineering Contradiction:
Improveantibacterial activityVSAvoidsynthesis and purification process
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The synthesis process is divided into distinct stages: esterification reaction followed by purification through column chromatography. This segmentation allows for systematic optimization of each step, achieving high purity products while maintaining manageable process complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses specific solvents and catalysts as intermediaries to facilitate the esterification reaction between hydroxytyrosol and cinnamic acid, enabling the transformation while keeping the process controllable and reproducible.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting hydroxytyrosol cinnamic acid ester demonstrates strong inhibitory effects against multidrug-resistant bacteria like MRSA and Pseudomonas aeruginosa, with significant antioxidant activity, making it a promising candidate for treating infectious diseases caused by resistant bacteria.

Implementation Method 1

reacting a compound of formula (II) with a compound of formula (III) to obtain a compound of formula (I)

Methodology Applied
Scientific EffectEsterification: Chemical Bonding

Implementation Method 2

heating the reaction mixture at 50-80° C. for 4-8 hours

Methodology Applied
Scientific EffectHeating: Heating

Implementation Method 3

purifying the crude product on a silica gel fresh chromatography column with petroleum ether and ethyl acetate as an eluent

Methodology Applied
Scientific EffectChromatography: Chromatography

Implementation Method 4

the catalyst being 12-molybdosilicic acid hydrate (H6Mo12O41Si); adding the compound of formula (III) to the reactor to form a reaction mixture

Methodology Applied
Scientific EffectIonic liquid catalysis: Catalysis

Data Source

PatentUS11427526B2Method of preparing hydroxytyrosol cinnamic acid ester with antioxidant and antibacterial activities
Publication Date: 2022.08.30 XIAN KANGYUANSHENG BIOMEDICAL TECH CO LTD
  • US11427526B2 patent drawing
  • US11427526B2 patent drawing
  • US11427526B2 patent drawing

AI summary

A method of preparing a compound of formula (I):is disclosed. The compound of formula (I) can be used as an antioxidant agent. The compound can also be used as an antibacterial agent to inhibit Staphylococcus aureus MRSA 18-222 and Pseudomonas aeruginosa MDR-PA 18-1774.